Q3 FY2026 · ended Apr 30, 2026 · Revenue $179,000, -50.6% YoY · Filed Jun 11, 2026
Rafael Holdings, Inc. (RFL) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$8.4 million.
Revenue
$179,000
-50.6% vs year-ago quarter
Net income
$-9.18M
-3064.1% vs year-ago quarter
Operating cash flow
$-8.37M
+19.3% vs year-ago quarter
Free cash flow
$-8.38M
+19.3% vs year-ago quarter
EPS
$-0.18
-2482.8% vs year-ago quarter
Dividend per share
None
Shares outstanding
100
Net cash
—
Operating margin
-3838.0%
Q3 FY2026
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RFL (NYSE)
- Fiscal year ends
- July 31
- Incorporated in
- DE
- Headquarters
- Newark, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1713863
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q4 FY2026 Jul 31, 2026 |
Q3 FY2026 Apr 30, 2026 |
Q2 FY2026 Jan 31, 2026 |
Q1 FY2026 Oct 31, 2025 |
Q4 FY2025 Jul 31, 2025 |
|---|---|---|---|---|---|
| Revenue | — | $179,000 | $211,000 | $240,000 | $350,000 |
| Operating income | -$9.7M | -$6.9M | -$6.7M | -$10.1M | -$12.8M |
| Net income | -$9.2M | -$4.2M | -$6.4M | -$9.8M | -$290,000 |
| Diluted EPS | -$0.18 | -$0.08 | -$0.13 | -$0.19 | -$0.01 |
| Operating cash flow | -$8.4M | -$7.3M | -$7.5M | -$6.8M | -$10.4M |
| Free cash flow | -$8.4M | -$7.3M | -$7.5M | — | -$10.4M |
| Total assets | $83.1M | $92.0M | $99.3M | $105.4M | $114.1M |
| Total liabilities | $11.1M | $11.2M | $16.1M | $16.2M | $15.7M |
| Stockholders' equity | $66.3M | $75.4M | $79.2M | $85.2M | $94.4M |
| Cash and investments | $22.9M | $31.2M | $38.5M | $46.0M | $52.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Oct 29, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 8, 2026 | Jul 8, 2026 |
| 10-Q | Quarterly report | Jun 11, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jun 11, 2026 | Jun 11, 2026 |
All 409 Rafael Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.